Skip to content

Efficacy of ''Malva sylvestris"on functional constipation .

determination of the efficacy of ''Malva sylvestris"on adult functional constipation in Traditional Iranian Medicine.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014031617032N1
Enrollment
110
Registered
2014-07-12
Start date
2013-12-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation. constipation

Interventions

Intervention 1: In malva sylvestris group, syrup is given 10cc twice daily,2 hours after breakfast and lunch for 4 weeks. Intervention 2: In placebo group, DW50% syrup approves 10 cc twice daily,2hou
Treatment - Drugs
In malva sylvestris group, syrup is given 10cc twice daily,2 hours after breakfast and lunch for 4 weeks.
In placebo group, DW50% syrup approves 10 cc twice daily,2hours after breakfast and lunch for 4 weeks.

Sponsors

Faculty of Traditional Medicines,Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Men and women aged 18–65 as having at least two or more of the following, during 25% of defecation times: very hard and/or hard stools; sensation of incomplete evacuation; straining at defecation; a need for digital manipulation to facilitate evacuation.These criteria should have been fulfilled for the 3 previous months with symptom onset at least 6 months prior to diagnosis. Exclusion criteria:Men and women 65 years;patients with mentioned criteria & drug-induced constipation, patients suffering from secondary causes of chronic constipation, including endocrine, metabolic, or neurological disorders; patients with a history of gastrointestinal surgery(exception of appandectomy and cholecystectomy); those with a diagnosis of constipation dominant IBS; Patients with alarming symptoms (fever, recent weight loss , and anaemia)& constipation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Defecation rate per week on average. Timepoint: before interventing &2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.;Hard stools. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire& Bristol stool form scale.;Need for digital manipulation to facilitate evacuation. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.;Sensation of blockage. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.;Straining of defecation. Timepoint: before interventing & 2,4 weeks aftertreatment. Method of measurement: ROME III questionnaire.

Secondary

MeasureTime frame
Rarely dyspepcia. Timepoint: every time patient reports. Method of measurement: patient report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahin Elsagh

Faculty of Traditional Medicines ,Iran University of Medical Science

Elsaghm@yahoo.com+98 21 3395 0154

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 18, 2026